Suzuki Tatsuya, Shibahara Hiroaki, Hirano Yuki, Ohno Akiko, Takamizawa Satoru, Suzuki Mitsuaki
Department of Obstetrics and Gynecology, Jichi Medical School, Tochigi, Japan.
Reprod Med Biol. 2004 May 20;3(2):99-104. doi: 10.1111/j.1447-0578.2004.00056.x. eCollection 2004 Jun.
The number of embryos transferred is very important to avoid multiple pregnancies without compromising pregnancy rates in fertilization (IVF)/intracytoplasmic sperm injection (ICSI)-embryo transfer (ET). We established criteria for the elective transfer of two embryos (age <40, first treatment cycle, good-quality embryos ≥3) to avoid high-order multiple pregnancies, and reported their usefulness. In the current study, we compared the clinical outcome of day 2 versus day 3 elective transfer of two good-quality embryos, in order to investigate the day of preferential transfer. A total of 228 cycles were treated with IVF/ICSI-ET from August 1999 to August 2002. From this total, 114 patients who were less than 40 years old and also had a first treatment cycle were enrolled in the present study (50.0%). The elective transfer of two good-quality embryos was carried out in 36 cycles (31.6%). Patients were randomized for transfer on either day 2 or day 3 after oocyte retrieval. The pregnancy rate of women who received two good-quality embryos was 44.4% (16 out of 36). The multiple pregnancy rate was 12.5% (two out of 16) and all pregnancies outcomes were twins. There were no significant differences between day 2 and day 3 ET for the following criteria: the number of cycles (24, 12); age (32.8 ± 3.4 years, 32.5 ± 2.7 years); number of oocytes retrieved (10.0 ± 3.3, 9.0 ± 6.0); number of embryos developed (7.6 ± 3.5, 6.9 ± 3.7); and number of good-quality embryos cryopreserved (3.5 ± 2.7, 3.6 ± 2.1). Higher pregnancy and implantation rates were obtained in day 3 ET than day 2 ET (37.5 and 20.8% in day 2 ET 58.3 and 33.3% in day 3 ET); however, there were no significant differences. Day 3 ET appears to be preferable to achieve more viable embryos than day 2 ET. (Reprod Med Biol 2004; : 99-104).
在体外受精(IVF)/卵胞浆内单精子注射(ICSI)-胚胎移植(ET)中,为避免多胎妊娠且不影响妊娠率,移植胚胎的数量非常重要。我们制定了选择性移植两个胚胎的标准(年龄<40岁、首次治疗周期、优质胚胎≥3个)以避免高阶多胎妊娠,并报告了其有效性。在本研究中,我们比较了优质胚胎选择性移植第2天和第3天的临床结局,以探讨优先移植的日期。1999年8月至2002年8月共有228个周期接受了IVF/ICSI-ET治疗。其中,114例年龄小于40岁且为首次治疗周期的患者纳入本研究(占50.0%)。36个周期(占31.6%)进行了两个优质胚胎的选择性移植。患者在取卵后第2天或第3天随机进行移植。接受两个优质胚胎移植的女性妊娠率为44.4%(36例中的16例)。多胎妊娠率为12.5%(16例中的2例),所有妊娠结局均为双胎。对于以下标准,第2天和第3天胚胎移植之间无显著差异:周期数(24、12);年龄(32.8±3.4岁、32.5±2.7岁);取卵数(10.0±3.3、9.0±6.0);发育的胚胎数(7.6±3.5、6.9±3.7);冷冻保存的优质胚胎数(3.5±2.7、3.6±2.1)。第3天胚胎移植的妊娠率和着床率高于第2天胚胎移植(第2天胚胎移植分别为37.5%和20.8%,第3天胚胎移植分别为58.3%和33.3%);然而,差异无统计学意义。与第2天胚胎移植相比,第3天胚胎移植似乎更有利于获得更多有活力的胚胎。(《生殖医学与生物学》2004年;:99 - 104)